For investors

X-ZELL brings same-day multiplex immunocytology to hospital pathology labs. Cytology is the cheapest, fastest way to sample a tumour, and the one that has waited longest for modern immunodiagnostics. X-ZELL's platform puts seven markers on one slide in under four hours, is CE-marked under EU IVDR, and is in routine use in German hospitals. The company is founder-led, based in Bangkok, and funded by private investors. We are always happy to talk to investors who share our passion and patience in bringing same-day diagnostics into clinical practice.